Quanterix to acquire akoya biosciences, creating the first integrated solution for ultra-sensitive detection of blood- and tissue-based protein biomarkers

Billerica, mass. and marlborough, mass.--(business wire)--quanterix corporation (nasdaq: qtrx), a company fueling scientific discovery through ultra-sensitive biomarker detection, and akoya biosciences (nasdaq: akya), the spatial biology company®, today announced a definitive merger agreement under which quanterix will acquire akoya in an all-stock transaction. the transaction will create the first integrated solution for ultra-sensitive detection of blood- and tissue-based protein biomarkers.
AKYA Ratings Summary
AKYA Quant Ranking